SUSPENSION INQUIRY - MAILED
mailed
on 13 Nov 2024
Last Applicant/ Owned by
4100-1155, boulevard René-Lévesque Ouest
Montréal (Québec)
CA
H3B3V2
Serial Number
97115991 filed on 09th Nov 2021
Registration Number
N/A
Correspondent Address
Benjamin M. Cantor
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
HEALTH IS IN OUR NATURE
Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97115991
Mark Type
No Service Mark
Attorney Docket Number
No SWA0583TUS
44D Filed
Yes
44D Current
Yes
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Nov 2024 | INQUIRY TO SUSPENSION E-MAILED |
| 13th Nov 2024 | SUSPENSION INQUIRY WRITTEN |
| 13th Nov 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| 28th Oct 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| 29th Jan 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 29th Jan 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 29th Jan 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 06th Dec 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 06th Dec 2023 | LETTER OF SUSPENSION E-MAILED |
| 06th Dec 2023 | SUSPENSION LETTER WRITTEN |